Process for the preparation of (3E, 7E)-homofarnesol
US-9493385-B2 · Nov 15, 2016 · US
US2016200648A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016200648-A1 |
| Application number | US-201514804747-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jul 21, 2015 |
| Priority date | Apr 16, 2012 |
| Publication date | Jul 14, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to new types of processes for the improved preparation of homofarnesol, in particular of (3E,7E)-homofarnesol and homofarnesol preparations with an increased content of (3E,7E)-homofarnesol (also referred to as all E-homofarnesol).
Opening claim text (preview).
1 .- 12 . (canceled) 13 . A process for preparing (3E,7E)-homofarnesol of formula Ia which comprises a) reacting a carbonyl compound of the formula II in which R 1 is where the dotted line represents a bond to the carbonyl carbon of formula II, and R 2 is methyl, by means of Wittig olefination to give a cyclopropane of the general formula (III) in which R 1 and R 2 have the meanings given above, b) reacting the cyclopropane of the formula III with ring opening in the presence of a Lewis acid or a Brönstedt acid/protonic acid, and a nucleophile, to give a compound of the formula IV in which R 1 and R 2 have the meanings given above, and X is halogen or O—R′, in which R′ is acyl, Tf-acetyl or SO 2 —R″, in which R″ is alkyl or aryl, wherein the ring opening exhibits E-selectively, with respect to R 1 , with a E:Z ratio of greater than 2:1; and c) converting the compound of the general formula IV to the compound of the general formula I by, when X is OR′, carrying out an ester cleavage, or when X is halogen, converting the halide to an ester and then cleaving this ester. 14 . The process according to claim 13 , wherein a cyclopropylphosphonium salt is used for the Wittig olefination according to stage a). 15 . The process according to claim 14 , wherein the cyclopropylphosphonium salt is a triphenylphosphonium compound of the formula V in which Z − is the anion of a strong acid. 16 . The process according to claim 15 , wherein Z is a halide. 17 . The process according to claim 15 , wherein Z is bromide. 18 . The process according to claim 15 , wherein the compound of the formula V is prepared by reacting a) bromobutyrolactone with triphenylphosphine and then thermally decarboxylating the reaction product, or b) reacting 1,3-dibromopropane with triphenylphosphine and then cyclizing the reaction product. 19 . The process according to claim 13 , wherein, in stage c), the compound of the general formula IV is converted to a compound of the general formula I by, when X is OR′, carrying out an ester cleavage, or when X is halogen, converting the halide to an ester and then cleaving this ester. 20 . The process according to claim 13 , wherein, in stage c), the compound of the general formula IV is converted to a compound of the general formula I by, when X is OR′, carrying out an ester cleavage, or when X is halogen, converting the halide to a formate ester, and then cleaving this ester. 21 . The process according to claim 13 , in which a product comprising a (3E,7E)-homofarnesol of the formula Ia is obtained. 22 . The process according to claim 13 , where, in stage a), E-geranyl acetone of the formula IIa is reacted with cyclopropylphosphonium halogenide, so that the cyclopropane of the formula IIIa is obtained. 23 . A compound of the formula IIIa 24 . A process for preparing enantiomerically pure ambrox or a stereoisomer mixture of ambrox, the process comprising; preparing (3E,7E)-homofarnesol by the process according to claim 13 , and conducting a cyclization reaction of the (3E,7E)-homofarnesol chemically or enzymatically to give enantiomerically pure ambrox or a stereoisomer mixture of ambrox.
with a three-membered ring · CPC title
by elimination of halogen, e.g. by hydrogenolysis, splitting-off (C07C29/124 takes precedence) · CPC title
Naphthofurans; Hydrogenated naphthofurans · CPC title
by reaction with aldehydes or ketones · CPC title
of halides · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.